Silencing of LncRNA AFAP1-AS1 Inhibits Cell Proliferation in Oral Squamous Cancer by Suppressing CCNA2

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386–396. doi:10.1016/j.mayocp.2015.12.01726944243
   PubMed Web of Science ®Google Scholar
• Kim D, Li R. Contemporary treatment of locally advanced oral cancer. Curr Treat Options Oncol. 2019;20(4):1–9. doi:10.1007/s11864-019-0631-8
   Web of Science ®Google Scholar
• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clinicians. 2016;66(4):271–289. DOI:10.3322/caac.21349
   PubMed Web of Science ®Google Scholar
• Knudsen ES, Pruitt SC, Hershberger PA, Witkiewicz AK, Goodrich DW. Cell cycle and beyond: exploiting new RB1 controlled mechanisms for cancer therapy. Trends Cancer. 2019;5(5):308–324. doi:10.1016/j.trecan.2019.03.00531174843
   PubMed Web of Science ®Google Scholar
• Sinevici N, O’sullivan J. Oral cancer: deregulated molecular events and their use as biomarkers. Oral Oncol. 2016;61:12–18. doi:10.1016/j.oraloncology.2016.07.01327688099
   PubMed Web of Science ®Google Scholar
• Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482(7385):339–346. doi:10.1038/nature1088722337053
   PubMed Web of Science ®Google Scholar
• Tang J, Yan T, Bao Y, et al. LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc. Nat Commun. 2019;10(1):1–15. doi:10.1038/s41467-019-11447-830602773
   PubMed Web of Science ®Google Scholar
• Yang Y, Wen L, Zhu H. Unveiling the hidden function of long non-coding RNA by identifying its major partner-protein. Cell Biosci. 2015;5(1):1–10. doi:10.1186/s13578-015-0050-x25601894
   PubMed Web of Science ®Google Scholar
• Wang Y, Lan Q. Long non-coding RNA AFAP1-AS1 accelerates invasion and predicts poor prognosis of glioma. Eur Rev Med Pharmacol Sci. 2018;22(16):5223–5229. doi:10.26355/eurrev_201808_1572030178845
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen D, Liu H, Yang K. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma. Cell Death Dis. 2019;10(2). doi:10.1038/s41419-018-1280-8
   Web of Science ®Google Scholar
• Yin D, Lu X, Su J, et al. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression. Mol Cancer. 2018;17(1):1–12. doi:10.1186/s12943-018-0836-729304823
   PubMed Web of Science ®Google Scholar
• Dai W, Tian Y, Jiang B, Chen W. Down-regulation of long non-coding RNA AFAP1-AS1 inhibits tumor growth, promotes apoptosis and decreases metastasis in thyroid cancer. Biomed Pharmacother. 2018;99(August2017):191–197. doi:10.1016/j.biopha.2017.12.10529331858
   PubMed Web of Science ®Google Scholar
• Zhang JY, Weng MZ, Bin SF, et al. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling. Int J Oncol. 2016;48(4):1590–1598. doi:10.3892/ijo.2016.338526892468
   PubMed Web of Science ®Google Scholar
• Ma F, Wang SH, Cai Q, Di ZM, Yang Y, Ding J. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer. Biomed Pharmacother. 2016;84:1249–1255. doi:10.1016/j.biopha.2016.10.06427810781
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chu Y, Sun J, Song R, Li Y, Xu F. LncRNA GAS8-AS inhibits colorectal cancer (CRC) cell proliferation by downregulating lncRNA AFAP1-AS1. Gene. 2019;710:140–144. doi:10.1016/j.gene.2019.05.04031132513
   PubMed Web of Science ®Google Scholar
• Fei D, Zhang X, Lu Y, Tan L, Xu M, Zhang Y. Long noncoding RNA AFAP1-AS1 promotes osteosarcoma progression by regulating miR-497/IGF1R axis. Am J Transl Res. 2020;12(5):2155–2168.32509208
   PubMed Web of Science ®Google Scholar
• Liu F, Hu L, Pei Y, et al. Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p/RAI14 axis. BMC Cancer. 2020;20(1):1–11. doi:10.1186/s12885-020-6665-2
   Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1). doi:10.1038/s41467-019-09234-6
   Web of Science ®Google Scholar
• Li T, Wu Q, Liu D, Wang X. miR-27b suppresses tongue squamous cell carcinoma epithelial-mesenchymal transition by targeting ITGA5. Onco Targets Ther. 2020;13:11855–11867. doi:10.2147/OTT.S28121133239888
   PubMed Web of Science ®Google Scholar
• Shen W, Yu L, Cong A, et al. Silencing lncRNA AFAP1-AS1 inhibits the progression of esophageal squamous cell carcinoma cells via regulating the miR-498/ VEGFA axis. Cancer Manag Res. 2020;12:6397–6409. doi:10.2147/CMAR.S25430232801880
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393–407. doi:10.1016/j.cell.2018.01.01129373828
   PubMed Web of Science ®Google Scholar
• Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22(9):1775–1789. doi:10.1101/gr.132159.11122955988
   PubMed Web of Science ®Google Scholar
• Wu W, Bhagat TD, Yang X, et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology. 2013;144(5):956–966. doi:10.1053/j.gastro.2013.01.01923333711
   PubMed Web of Science ®Google Scholar
• Zhang F, Li J, Xiao H, Zou Y, Liu Y, Huang W. AFAP1-AS1: a novel oncogenic long non-coding RNA in human cancers. Cell Prolif. 2018;51(1):1–11. doi:10.1111/cpr.12397
   Web of Science ®Google Scholar
• Wang F, Ni H, Sun F, Li M, Chen L. Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer. Biomed Pharmacother. 2016;81:152–159. doi:10.1016/j.biopha.2016.04.00927261589
   PubMed Web of Science ®Google Scholar
• Guo JQ, Li SJ, Guo GX. Long noncoding RNA AFAP1-AS1 promotes cell proliferation and apoptosis of gastric cancer cells via PTEN/p-AKT pathway. Dig Dis Sci. 2017;62(8):2004–2010. doi:10.1007/s10620-017-4584-028451917
   PubMed Web of Science ®Google Scholar
• Hao F, Mou Y, Zhang L, Wang S, Yang Y. LncRNA AFAP1-AS1 is a prognostic biomarker and serves as oncogenic role in retinoblastoma. Biosci Rep. 2018;38(3):1–8. doi:10.1042/BSR20180384
   Web of Science ®Google Scholar
• He J, Wu K, Guo C, et al. Long non-coding RNA AFAP1-AS1 plays an oncogenic role in promoting cell migration in non-small cell lung cancer. Cell Mol Life Sci. 2018;75(24):4667–4681. doi:10.1007/s00018-018-2923-830293090
   PubMed Web of Science ®Google Scholar
• Fu Z, Li G, Li Z, et al. Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells. Cell Death Discovery. 2017;3(1). doi:10.1038/cddiscovery.2017.4
   Web of Science ®Google Scholar
• Wu XB, Feng X, Chang QM, et al. Cross-talk among AFAP1-AS1, ACVR1 and microRNA-384 regulates the stemness of pancreatic cancer cells and tumorigenicity in nude mice. J Exp Clin Cancer Res. 2019;38(1):1–15. doi:10.1186/s13046-019-1051-030606223
   PubMed Web of Science ®Google Scholar
• Liu Y, Hu Q, Wang X. (2.311) AFAP1-AS1 induces cisplatin resistance in non-small cell lung cancer through PI3K/AKT pathway. Oncol Lett. 2020;19(1):1024–1030. doi:10.3892/ol.2019.1117531897216
   PubMed Web of Science ®Google Scholar
• Bi Z, Li Q, Dinglin X, et al. Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 silencing to block Wnt/β-Catenin signaling pathway for synergistic reversal of radioresistance and effective cancer radiotherapy. Adv Sci. 2020;7(18):1–14. doi:10.1002/advs.202000915
   Web of Science ®Google Scholar
• Zhang K, Liu P, Tang H, et al. AFAP1-AS1 Promotes epithelial-mesenchymal transition and tumorigenesis through Wnt/β-catenin signaling pathway in triple-negative breast cancer. Front Pharmacol. 2018;9:1–13. doi:10.3389/fphar.2018.0124829387012
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.050658010216199517
   PubMed Web of Science ®Google Scholar
• Meškytė EM, Keskas S, Ciribilli Y. MYC as a multifaceted regulator of tumor microenvironment leading to metastasis. Int J Mol Sci. 2020;21(20):7710. doi:10.3390/ijms21207710
   PubMed Web of Science ®Google Scholar
• Pérez-Sayáns M, Suárez-Peñaranda JM, Pilar GD, Barros-Angueira F, Gándara-Rey JM, García-García A. What real influence does the proto-oncogene c-myc have in OSCC behavior? Oral Oncol. 2011;47(8):688–692. doi:10.1016/j.oraloncology.2011.05.01621708481
   PubMed Web of Science ®Google Scholar
• Hua Q, Jin M, Mi B, et al. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol. 2019;12(1):1–18. doi:10.1186/s13045-019-0773-y30606227
   PubMed Web of Science ®Google Scholar
• Swier LJYM, Dzikiewicz-Krawczyk A, Winkle M, van den Berg A, Kluiver J. Intricate crosstalk between MYC and non-coding RNAs regulates hallmarks of cancer. Mol Oncol. 2019;13(1):26–45. doi:10.1002/1878-0261.1240930451365
   PubMed Web of Science ®Google Scholar
• Robson S, Pukonen I, Abouna S, Pelengaris S, Khan M. c-Myc and downstream targets in the pathogenesis and treatment of cancer. Front Anti-Cancer Drug Discov. 2011;340–379. doi:10.2174/978160805161811001010340
   Google Scholar
• Gao T, Han Y, Yu L, Ao S, Li Z, Ji A. CCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistance. PLoS One. 2014;9(3):1–5. doi:10.1371/journal.pone.0091771
   Web of Science ®Google Scholar
• Blanchard JM. Cyclin A2 transcriptional regulation: modulation of cell cycle control at the G1/S transition by peripheral cues. Biochem Pharmacol. 2000;60(8):1179–1184. doi:10.1016/S0006-2952(00)00384-111007956
   PubMed Web of Science ®Google Scholar
• Li T, Luo W, Liu K, Lv X, Xi T. miR-31 promotes proliferation of colon cancer cells by targeting E2F2. Biotechnol Lett. 2015;37(3):523–532. doi:10.1007/s10529-014-1715-y25362258
   PubMed Web of Science ®Google Scholar
• Infante A, Laresgoiti U, Fernández-Rueda J, et al. E2F2 represses cell cycle regulators to maintain quiescence. Cell Cycle. 2008;7(24):3915–3927. doi:10.4161/cc.7.24.737919066456
   PubMed Web of Science ®Google Scholar
• Ma HW, Xi DY, Ma JZ, et al. Long noncoding RNA AFAP1-AS1 promotes cell proliferation and metastasis via the miR-155-5p/FGF7 axis and predicts poor prognosis in gastric cancer. Dis Markers. 2020:2020. doi:10.1155/2020/8140989.
   Web of Science ®Google Scholar
• Shi D, Wu F, Mu S, et al. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway. J Exp Clin Cancer Res. 2020;39(1):1–12. doi:10.1186/s13046-020-01574-231928527
   PubMed Web of Science ®Google Scholar
• Li M, Yu D, Li Z, Zhao C, Su C, Ning J. Long non-coding RNA AFAP1-AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR-145/HOXA1 axis. Oncol Rep. 2021;45(3):1094–1104. doi:10.3892/or.2020.790833650645
   PubMed Web of Science ®Google Scholar
• Mei LL, Wang WJ, Qiu YT, Xie XF, Bai J, Shi ZZ. miR-145-5p suppresses tumor cell migration, invasion and epithelial to mesenchymal transition by regulating the sp1/NF-kB signaling pathway in esophageal squamous cell carcinoma. Int J Mol Sci. 2017;18(9):1833. doi:10.3390/ijms18091833
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhou Y, Mao F, Lin Y, Shen S, Sun Q. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression. Sci Rep. 2020;10(1):1–11. doi:10.1038/s41598-020-64713-x31913322
   PubMed Web of Science ®Google Scholar